FDA letter monthly archive

FDA Letters Issued in April 2019

Name: FDA Letters Issued in April 2019
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in April 2019. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Evoke Pharma, Inc. (Apr 1, 2019)
FDA's complete response letter contains source-text evidence related to Clinical efficacy and substantial evidence, Safety and adverse events, Chemistry, manufacturing, and controls, Device constituent and human factors. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedApr 1, 2019
US FDA• GIMOTI

Complete Response Letter Evoke Pharma, Inc. (Apr 1, 2019)